No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 18.370
- -0.100-0.54%
Close Jan 17 16:00 ET
- 18.370
- 0.0000.00%
Post 20:01 ET
1.60BMarket Cap-4.01P/E (TTM)
18.740High18.240Low879.45KVolume18.540Open18.470Pre Close16.19MTurnover1.19%Turnover RatioLossP/E (Static)87.03MShares20.33052wk High-52.49P/B1.36BFloat Cap5.12052wk Low--Dividend TTM73.88MShs Float37.040Historical High--Div YieldTTM2.71%Amplitude0.000Historical Low18.410Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Evercore Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $33
Travere Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Travere Therapeutics Analyst Ratings
H.C. Wainwright Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $22
Guggenheim Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $45
Express News | Travere Therapeutics Inc : Guggenheim Raises Target Price to $45 From $41
Heat List
US
Overall
Symbol
Price
% Chg
No Data